Inicio › Ateroesclerosis › Pensilvania
Ensayos clínicos de Ateroesclerosis en Pensilvania
11 estudios sobre Ateroesclerosis buscan participantes en Pensilvania.
Ciudades en Pensilvania
Texto oficial del estudio (inglés)
A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events
- Preferred Primary Care Physicians, Inc, Pittsburgh
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 29 sept 2026 · NCT07448038Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
- Lehigh Valley Health Network, Allentown
- Capital Area Research, LLC, Camp Hill
- Altoona Center For Clinical Research, Duncansville
- y 5 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 24 sept 2026 · NCT07157774A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis
- Capital Area Research, LLC - Camp Hill, Camp Hill
ReclutandoFase 2
Edades de 18 a 80 · Todos los sexos · Actualizado el 22 sept 2026 · NCT07521007A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Suburban Research Associates, West Chester
- Cardiology Consultants of Philadelphia Yardley, Yardley
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07783802A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk
- Heart and Vascular Research at WellSpan Health, York
ReclutandoFase 3
Edades de 45 a 80 · Todos los sexos · Actualizado el 22 sept 2026 · NCT07613294Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Heritage Valley Multispecialty Group Inc, Beaver
- Capital Area Research LLC, Camp Hill
- Abington Medical Specialists, Horsham
ReclutandoFase 3
Edades de 45 a 99 · Todos los sexos · Actualizado el 22 sept 2026 · NCT07037433Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Northeast Clinical Research Center, LLC, Bethlehem
- Clinical Renal Associates, LTD, Exton
ReclutandoFase 2/3
Edades de 18 en adelante · Todos los sexos · Actualizado el 21 sept 2026 · NCT05485961A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
- Research Site, Camp Hill
- Research Site, Horsham
- Research Site, Philadelphia
- y 5 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 24 ago 2026 · NCT07000357Pelacarsen Roll-over Extension Program
- Care Access Research, Easton
- TCV Clinical Studies, Linwood
ReclutandoFase 3
Edades de 18 a 100 · Todos los sexos · Actualizado el 29 jul 2026 · NCT06875973MetfOrmin BenefIts Lower Extremities With Intermittent Claudication
- VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA, Pittsburgh
ReclutandoFase 3
Edades de 35 a 89 · Todos los sexos · Actualizado el 21 abr 2026 · NCT05132439How Animal and Plant Protein Shakes Change the Body's Nutrient and Health Responses
- UPMC Montefiore - Clinical and Translational Research Center (CTRC), Pittsburgh
ReclutandoSe aceptan voluntarios sanos
Edades de 18 a 65 · Todos los sexos · Actualizado el 25 mar 2026 · NCT07121010De ClinicalTrials.gov, datos obtenidos el 30 sept 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.